Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: Development of tolerance using environmental antigens - 17/08/11
Reprint requests: Christine McCusker, MSc, MD, Meakins-Christie Laboratories, 3626 St Urbain, Montreal, Quebec H2X 2P2, Canada.Montreal, Quebec, Canada
Abstract |
Background |
Studies show that children in rural environments develop less asthma and allergic rhinitis than their urban counterparts. This may be a result, in part, of neonatal exposure to environmental antigens such as LPS and/or early exposure to allergens.
Objective |
This study examined the effects of neonatal allergen and/or LPS exposure on subsequent immune responses to allergen.
Methods |
Newborn mice were exposed to LPS and/or ovalbumin. At age 6 weeks, these animals were sensitized and challenged with ovalbumin, and airway inflammation, hyperresponsiveness, and cytokine expression were assessed.
Results |
Animals exposed to LPS in the neonatal period developed T cells expressing CD25 and IL-10 on sensitization and challenge. They demonstrated abrogation of airway hyperresponsiveness and significant decreases in IL-13 from bronchoalveolar lavage fluid and in specific IgE. IL-4–expressing spleen cells were also significantly decreased. Mice exposed in the neonatal period to ovalbumin demonstrated airway hyporesponsiveness after subsequent ovalbumin sensitization and challenge and did not produce specific IgE. In contrast, these animals showed increases in IFN-γ. Animals exposed to both LPS and ovalbumin developed a response characterized by IL-10 and IFN-γ–expressing T cells.
Conclusion |
This suggests that mucosal antigen exposure in the neonatal period results in inhibition of allergic responses to environmental allergens. Early LPS exposure directs mucosal responses toward tolerance, whereas ovalbumin exposure follows the TH1-type response on subsequent sensitization.
Clinical implications |
This study suggests that prevention of airways allergy may be best achieved by appropriate exposure of the airway mucosa early in life to environmental antigens.
Le texte complet de cet article est disponible en PDF.Key words : Asthma, allergic rhinitis, developmental immunology, allergy prevention, animal model, T-regulatory cells, lipopolysaccharide
Abbreviations used : BAL, KLH, NALT, OVA, TLR4, TR
Plan
| Supported by the Montreal Children’s Hospital Research Institute and the Canadian Institutes of Health Research. Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest. |
Vol 118 - N° 1
P. 143-151 - juillet 2006 Retour au numéro
Article précédent
- Analysis of gene expression profiles of normal human nasal mucosa and nasal polyp tissues by SAGE
- Jae Yong Lee, Sang Hag Lee, Heung Man Lee, Seung Hoon Lee, Hak Hyun Jung, Se Woo Lee, Sun Mook Kang
- Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report
- Cezmi A. Akdis, Mübeccel Akdis, Thomas Bieber, Carsten Bindslev-Jensen, Mark Boguniewicz, Philippe Eigenmann, Qutayba Hamid, Alexander Kapp, Donald Y.M. Leung, Jasna Lipozencic, Thomas A. Luger, Antonella Muraro, Natalija Novak, Thomas A.E. Platts-Mills, Lanny Rosenwasser, Annika Scheynius, F. Estelle R. Simons, Jonathan Spergel, Kristiina Turjanmaa, Ulrich Wahn, Stefan Weidinger, Thomas Werfel, Torsten Zuberbier, for the European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Group †
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?